Elicio Therapeutics, Inc. (ELTX) Gross margin 2020–2022
Elicio Therapeutics, Inc. (ELTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2022 · since FY2020: 58.7% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 100.0% | +1.5 pp |
| FY2021 | 98.5% | +39.8 pp |
| FY2020 | 58.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX RevenueELTX Net incomeELTX Net marginELTX Gross profitELTX Operating incomeELTX Operating marginELTX Operating cash flowELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Total liabilitiesELTX Shareholders’ equityELTX overview →